Issues

Article

Catak et al. describe the first case of homozygous CTLA-4 deficiency, which drives severe early-onset autoimmunity through profound T and B cell dysregulation. They show that the variant impairs protein stability, yet targeted therapy with abatacept successfully restores immune balance, highlighting new clinical strategies for CTLA-4–related disorders.

News & Views

A report in this issue of JHI deepens our understanding of human disease associated with loss of CTLA-4.